Arcutis Enrolls First Patient in Phase 1b Alopecia Areata Study Evaluating ARQ-255
December 05, 2022 08:00 ET
|
Arcutis Biotherapeutics, Inc.
ARQ-255 is a topical janus kinase (JAK) inhibitor therapy specifically designed as a potential treatment for alopecia areataProprietary Deep Dermal Drug Delivery (4D) formulation designed to deliver...
Throne Biotechnologies Wins '5 Best BioTech Companies To Watch' Award From The Silicon Review
March 28, 2022 09:00 ET
|
Throne Biotechnologies Inc
PARAMUS, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Throne Biotechnologies (Throne), one of the global-leading biotech companies aiming to find a cure for type 1 diabetes and other autoimmune...
Throne Biotechnologies Launches Equity Crowdfunding to Support Phase 2 Clinical Trials in Type 1 Diabetes and Alopecia Areata
February 28, 2022 09:00 ET
|
Throne Biotechnologies Inc
PARAMUS, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Throne Biotechnologies, one of the global-leading biotech companies aiming to find a cure for type 1 diabetes, announced the launch of their...
Alopecia Areata Clinical Trials Report: Pipeline Insight 2021 by DelveInsight
March 23, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 23, 2021 (GLOBE NEWSWIRE) -- Alopecia Areata Clinical Trials Report: Pipeline Insight 2021 by DelveInsight The increasing R&D investments for strong Alopecia Areata...
Alopecia Market To Reach USD 12.99 Billion By 2026 | Reports And Data
April 25, 2019 13:26 ET
|
Reports And Data
Rising incidences of chronic disorders such as hyperthyroidism, acute stress disorder hypopituitarism, hypothyroidism, and lupus are the major factors influencing market growth. Market Size – USD...
My Choice Hair Launches to Provide Hair Replacement Solutions
May 25, 2018 12:16 ET
|
My Choice Hair
FORT LAUDERDALE, Fla., May 25, 2018 (GLOBE NEWSWIRE) -- My Choice Hair, a hair replacement franchise, from the makers of ST Hair and New Concepts Hair Products is proud to unveil the new brand...
TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update
November 04, 2015 16:01 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Nov. 4, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata
November 02, 2015 07:00 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Nov. 2, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a Phase...
NAAF Is There to Help Children Discriminated Because of Alopecia Areata
March 26, 2014 16:21 ET
|
National Alopecia Areata Foundation
SAN RAFAEL, Calif., March 26, 2014 (GLOBE NEWSWIRE) -- The National Alopecia Areata Foundation (NAAF) works with children with alopecia areata and their families who encounter problems with their...
11-Year-Old with Rare Autoimmune Disease Throws First Pitch for Royals
September 07, 2012 09:12 ET
|
National Alopecia Areata Foundation
SAN RAFAEL, Calif., Sept. 7, 2012 (GLOBE NEWSWIRE) -- When the Kansas City Royals face the Cleveland Indians on Sunday, September 23, they will have a "ringer" in their corner. Courtney Whitney, who...